Neurocrine Biosciences | Handelsfordringar



Trade Creditors Ändra Datum
AbbVie 2.94B 2.66B 2024-12
Acadia Pharmaceuticals USD 16.19M 2.89M 2024-12
Agios Pharmaceuticals USD 16.64M 500K 2024-12
ALKERMES USD 45.63M 8.59M 2024-12
Alnylam Pharmaceuticals USD 88.42M 17.61M 2024-12
Amgen USD 1.91B 239M 2024-12
Biogen USD 424.2M 1.5M 2024-12
BioMarin Pharmaceutical 715.66M 458.25M 2024-09
Cytokinetics USD 20.37M 8.79M 2024-12
Dynavax Technologies USD 9.06M 1.97M 2024-12
Exelixis USD 38.19M 21.12M 2025-01
Gilead Sciences USD 833M 70M 2024-12
Halozyme Therapeutics USD 10.25M 2.15M 2024-12
Incyte USD 197.46M 18.76M 2024-12
Intra Cellular Therapies USD 26.07M 15.74M 2024-12
Ionis Pharmaceuticals USD 42.96M 33.91M 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
Pfizer USD 5.63B 319M 2024-12
Prothena USD 7.77M 2.56M 2024-12
Regeneron Pharmaceuticals USD 4.89B 4.39B 2024-12
Repligen USD 21.36M 447K 2024-09
Sarepta Therapeutics USD 214.44M 95.67M 2024-12
Teva Pharmaceutical Industries USD 2.2B 168M 2024-12
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Neurocrine Biosciences Handelsfordringar - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2025.